ENVERIC BIOSCIENCES INC

ENVB03 Dec 2024
Healthcare
$0.34
-0.01 (-0.97%)
Lowest Today
$0.3
Highest Today
$0.34
Today’s Open
$0.34
Prev. Close
$0.33
52 Week High
$1.9
52 Week Low
$0.31
To Invest in ENVERIC BIOSCIENCES INC

ENVERIC BIOSCIENCES INC

Healthcare
ENVB03 Dec 2024
-0.01 (-0.97%)
1M
3M
6M
1Y
5Y
Low
$0.3
Day’s Range
High
$0.34
0.3
52 Week Low
$0.31
52-Week Range
52 Week High
$1.9
0.31
1 Day
-
1 Week
-3.08%
1 month return
-36.75%
3 month return
-32.06%
6 month return
-55.47%
1 Year return
-78.03%
3 Years return
-99.49%
5 Years return
-99.92%
10 Years return
-
Institutional Holdings
AdvisorShares Psychedelics ETF
6.99
AdvisorShares Investments, LLC
4.08
Geode Capital Management, LLC
2.42
Fidelity Nasdaq Composite Index
1.82
UBS Group AG
0.48
Fidelity Extended Market Index
0.48
BlackRock Inc
0.33

Market Status

Fundamentals
Market Cap
3.24 mln
PB Ratio
0.82
PE Ratio
0
Enterprise Value
-3.83 mln
Total Assets
4.3 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Organisation
ENVERIC BIOSCIENCES INC
Employees
7
Industry
Biotechnology
CEO
Dr. Joseph Edward Tucker Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities